Gapping up
In reaction to strong earnings/guidance: CMA +7.8%, WWW +4.3%, JPM +2.6%, PPHM +2.3%, GS +1.8%, SABA +0.8%.
Select financial related names showing strength: IBN +2.8%, RBS +2.2%, DB +2%, MS +1.7%, BCS +1.6%, BAC +1.3%, C +0.9%.
Select metals/mining stocks trading higher: SQM +5.5%, ZQK +2.6%, AUY +1.3%, GOLD +1.1%, GOLD +1.1%.
Other news: CDXS +87.9% (announces technology collaboration and license agreement with GSK), LJPC +11.5% (announces positive pre-clinical data for oral galectin-3 inhibitor in nonalcoholic steatohepatitis), CBMX +10.9% (Pediatric Development disorders analysis test granted conditional approval from New York State Department of Health), ANTH +5.9% (following acquisition of therapy Sollpura from Eli Lilly (LLY)), FCEL +5.1% (may be attributed to PLUG initiation at FBR), GRH +4.4% (following yesterday's ~30% move higher), LGF +3.7% (co and Alibaba (BABA) form strategic collaboration to offer Lionsgate Entertainment World Service in China), YGE +2.4% (signs a EPC contract with Senelec for a 2 MW project), APC +1.3% (provided a financial update, including the establishment of a new unsecured five-year credit facility, the issuance of senior notes, and the sale of Western Gas Equity Partners (WGP) common units), SAVE +0.8% (Lone Pine Capital discloses 6.0% passive stake in 13G filing).
Analyst comments: PLUG +13.6% (initiated with a Outperform at FBR Capital), GPRO +4.6% (initiated with a Mkt Outperform at JMP Securities), GLUU +3.4% (target raised to $9 from $7.50 at Northland Capital), PHH +1.5% (upgraded to Outperform at Oppenheimer), WDC +0.8% (initiated with a Positive at Susquehanna), SSRI +0.8% (upgraded to Outperform from Mkt Perform at BMO Capital Mkts)
In reaction to strong earnings/guidance: CMA +7.8%, WWW +4.3%, JPM +2.6%, PPHM +2.3%, GS +1.8%, SABA +0.8%.
Select financial related names showing strength: IBN +2.8%, RBS +2.2%, DB +2%, MS +1.7%, BCS +1.6%, BAC +1.3%, C +0.9%.
Select metals/mining stocks trading higher: SQM +5.5%, ZQK +2.6%, AUY +1.3%, GOLD +1.1%, GOLD +1.1%.
Other news: CDXS +87.9% (announces technology collaboration and license agreement with GSK), LJPC +11.5% (announces positive pre-clinical data for oral galectin-3 inhibitor in nonalcoholic steatohepatitis), CBMX +10.9% (Pediatric Development disorders analysis test granted conditional approval from New York State Department of Health), ANTH +5.9% (following acquisition of therapy Sollpura from Eli Lilly (LLY)), FCEL +5.1% (may be attributed to PLUG initiation at FBR), GRH +4.4% (following yesterday's ~30% move higher), LGF +3.7% (co and Alibaba (BABA) form strategic collaboration to offer Lionsgate Entertainment World Service in China), YGE +2.4% (signs a EPC contract with Senelec for a 2 MW project), APC +1.3% (provided a financial update, including the establishment of a new unsecured five-year credit facility, the issuance of senior notes, and the sale of Western Gas Equity Partners (WGP) common units), SAVE +0.8% (Lone Pine Capital discloses 6.0% passive stake in 13G filing).
Analyst comments: PLUG +13.6% (initiated with a Outperform at FBR Capital), GPRO +4.6% (initiated with a Mkt Outperform at JMP Securities), GLUU +3.4% (target raised to $9 from $7.50 at Northland Capital), PHH +1.5% (upgraded to Outperform at Oppenheimer), WDC +0.8% (initiated with a Positive at Susquehanna), SSRI +0.8% (upgraded to Outperform from Mkt Perform at BMO Capital Mkts)